Non-infectious Uveitis drugs in development, 2024

GlobalData tracks 19 drugs in development for Non-infectious Uveitis by 20 companies/universities/institutes. The top development phase for Non-infectious Uveitis is preclinical, with seven drugs in that stage.

A fraught question for the children of Alzheimer’s: Is it coming for us?

My sister has a fantasy about our old age: She imagines that the seven siblings in our family will be living together again, in a

October 10, 2023

Gingko biloba compound injections linked to better stroke outcomes

People with ischemic (clot-caused) stroke had better early recovery of cognitive function if treated with intravenous injections of a combination of biologically active components of

February 1, 2024

Promising red-light myopia treatment for children is raising safety concerns among experts

Myopia, or near-sightedness, is on the rise: Nearly half of the world’s population will be nearsighted by 2050, according to the World Health Organization. The condition

February 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.